Cue is a healthcare technology company that enables people to manage their health through actionable and connected health data.
Cue helps users track their health at the molecular level, revealing the interplay of activity, food, and sleep. Consumers can track five key health and lifestyle indicators: inflammation, vitamin D, fertility, influenza, and testosterone in just minutes, at home. The Cue sends the data via Bluetooth 4.0 to the user's smartphone, where the free Cue app reveals the interplay of activity, food, and sleep shaping the user at a molecular level.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 6, 2022 | Grant | — | 1 | Biomedical Advanced Research and Development Authority (BARDA) | — | Detail |
Sep 23, 2021 | IPO | $200M | — | — | — | Detail |
May 13, 2021 | Series Unknown | $235M | 7 | — | — | Detail |
Oct 14, 2020 | Grant | $481M | 2 |
U.S. Department of Defense
U.S. Department of Health & Human Services |
— | Detail |
Jun 10, 2020 | Series C | $102.60M | 5 | — | — | Detail |